Who founded Neuralight?

Neuralight was founded by Edmund Ben-Ami, Edmund Benami, Gil Shklarski in 2021.

Who are Neuralight's investors?

Neuralight's investors include MS&AD Ventures, Alumni Ventures, Breyer Capital, Koch Disruptive Technologies, Samsung Next, VSC Ventures, Wormhole Capital, Kli Capital and 2 more.

How much funding has Neuralight raised?

Neuralight has disclosed $30.5M raised across 2 rounds.

Where is Neuralight headquartered?

Neuralight is headquartered in Tel Aviv, IL.

Neuralight

Tel Aviv, IL · Founded 2021 · 29 employees on LinkedIn · 16 known investors

Find your way into Neuralight

Paths you didn't know you had: your email and LinkedIn already hold routes to the Neuralight team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.

AI & Machine Learning Biotech Healthtech Medical Devices

Founders & leadership

Neuralight was founded in 2021 by Edmund Ben-Ami, Edmund Benami, and Gil Shklarski.

Edmund Ben-Ami Co-Founder & CEOFounder of NeuraLight, which uses signal processing and computer vision to develop AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis.

Edmund BenamiFounder

Gil Shklarski Investor, Board Observer, Scientific Co-FounderGeneral Partner at Operator LP

Eddy

Board

Prof. Thomas Südhof

Prof. Olivier Rascol

Investors · 16

MS&AD Ventures✓ confirmed by NeuralightMenlo Park · $500K – $3M

How we know: the company's own site · MS&AD Ventures's portfolio page · Not right? Tell us

Alumni Ventureslisted by Alumni VenturesManchester · $100K – $10M

How we know: av.vc · Not right? Tell us

Breyer Capitallisted by Breyer CapitalAustin · $500K – $10M

How we know: Breyer Capital's portfolio page · calcalistech.com · the VCSheet dataset · Not right? Tell us

Koch Disruptive Technologieslisted by Koch Disruptive TechnologiesSan Francisco

How we know: calcalistech.com · Not right? Tell us

Samsung Nextlisted by Samsung NextMountain View · $100K – $5M

How we know: Samsung Next's portfolio page · calcalistech.com · Not right? Tell us

VSC Ventureslisted by VSC VenturesSan Francisco · $500K – $750K

How we know: VSC Ventures's portfolio page · techcrunch.com · Not right? Tell us

Wormhole Capitallisted by Wormhole Capital

How we know: Wormhole Capital's portfolio page · a partner's Signal profile · Not right? Tell us

Kli CapitalreportedChamplain · $500K – $2M

How we know: calcalistech.com · Not right? Tell us

Operator PartnersreportedNew York

How we know: techcrunch.com · Not right? Tell us

Tuesday CapitalreportedSan Francisco

How we know: funding news · calcalistech.com · Not right? Tell us

Also in the syndicate · 6

KliKock Disruptive TechnologiesleadMSADMSAD.vcleadNEXTSamsung

Funding

SEC filings, press & company announcements

$30.5M disclosed across 2 rounds · 2021–2022

$25MSeries AMay 2022 · 2 sources
Koch Disruptive Technologies (lead), Kock Disruptive Technologies (lead), Breyer Capital, NEXT, Samsung, Samsung NEXT, VSC Ventures
Source ↗
$5.5MseedOct 2021 · 3 sources
Kli Capital (lead), MSAD.vc (lead), Tuesday Capital (lead), Kli, MSAD, Operator Partners, VSC Ventures
Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

Related companies · 4

Neuron23Neuron23 is a biotech company using data science, human genetics, and functional genomics to develop precision medicines and companion diagnostics for neurodegenerative diseases, starting with an LRRK2 program for Parkinson's disease. It aims to match patient subsets defined by genetic drivers with targeted therapies for conditions such as Parkinson's and Alzheimer's.

Neuralink-LogoArtboard-1Neurotechnology company developing implantable brain-computer interfaces for people with paralysis and vision loss.

StartUp HealthStartUp Health operates a private global membership community for health innovators — including founders, healthcare executives, investors, and clinicians — offering a member network app, live AMAs and fireside chats, in-person event access, and a content library. It focuses on connecting and supporting people working on digital health and healthcare innovation.

NeurobladeNeuroBlade builds the SQL Processing Unit (SPU), a purpose-built processor that accelerates complex query execution and analytical workloads, integrating with data frameworks such as Spark, Presto, and ClickHouse. It is deployable in the cloud via EC2 instances or on-premises through PCIe cards, serving organizations running large-scale data analytics.

Companies working in the same space as Neuralight.

In the news

NeuraLight emerges from stealth with $5.5M to digitize neurological evaluation and care | TechCrunchtechcrunch.com · Oct 2021

Frequently asked questions

What does Neuralight do?: NeuraLight develops AI-powered digital biomarkers for neurological diseases including Alzheimer's, Parkinson's, and multiple sclerosis. The company uses signal processing and computer vision to enable clinical assessment and disease monitoring for healthcare providers and medical institutions.
Who founded Neuralight?: Neuralight was founded by Edmund Ben-Ami, Edmund Benami, Gil Shklarski in 2021.
Who are Neuralight's investors?: Neuralight's investors include MS&AD Ventures, Alumni Ventures, Breyer Capital, Koch Disruptive Technologies, Samsung Next, VSC Ventures, Wormhole Capital, Kli Capital and 2 more.
How much funding has Neuralight raised?: Neuralight has disclosed $30.5M raised across 2 rounds.
Where is Neuralight headquartered?: Neuralight is headquartered in Tel Aviv, IL.